CPT Codes For Multianalyte Assay
Below is a list summarizing the CPT codes for multianalyte assay.
CPT Code 0002M
CPT 0002M describes ten biochemical assays (ALT, A2-macroglobulin, apolipoprotein A-1, total bilirubin, GGT, haptoglobin, AST, glucose, total cholesterol, and triglycerides) utilizing serum and a prognostic algorithm reported as quantitative scores for fibrosis, steatosis, and alcoholic steatohepatitis (ASH) to assess the liver disease.
CPT Code 0003M
CPT 0003M describes ten biochemical assays (ALT, A2-macroglobulin, apolipoprotein A-1, total bilirubin, GGT, haptoglobin, AST, glucose, total cholesterol, and triglycerides) utilizing serum and a prognostic algorithm reported as quantitative scores for fibrosis, steatosis, and nonalcoholic steatohepatitis (NASH) to assess the liver disease.
CPT Code 0004M
CPT 0004M describes a prognostic algorithm reported as a risk score, which uses DNA analysis of 53 single nucleotide polymorphisms (SNPs) from saliva to assess scoliosis.
CPT Code 0006M
CPT 0006M describes a risk classifier algorithm utilizing fresh hepatocellular carcinoma tumor tissue and mRNA expression levels of 161 genes, with alpha-fetoprotein level, for oncology (hepatic).
CPT Code 0007M
CPT 0007M describes real-time PCR expression analysis of 51 genes utilizing whole peripheral blood, with an algorithm reported as a nomogram of tumor disease index for Oncology (gastrointestinal neuroendocrine tumors).
CPT Code 0011M
CPT 0011M describes an RT-PCR test utilizing blood plasma and urine to measure mRNA expression of 12 genes (10 content and two housekeeping) with algorithms to predict high-grade prostate cancer risk in oncology.
CPT Code 0012M
CPT 0012M describes a gene expression profiling algorithm reported as a risk score for having urothelial carcinoma, utilizing urine and real-time quantitative PCR of five genes (MDK, HOXA13, CDC2 [CDK1], IGFBP5, and CXCR2) in an oncology (urothelial) setting.
CPT Code 0013M
CPT 0013M describes a gene expression profiling algorithm reported as a risk score for having recurrent urothelial carcinoma, utilizing urine and real-time quantitative PCR of five genes (MDK, HOXA13, CDC2 [CDK1], IGFBP5, and CXCR2) in oncology (urothelial).
CPT Code 0014M
CPT 0014M describes the analysis of three biomarkers (hyaluronic acid [HA], procollagen III amino terminal peptide [PIIINP], tissue inhibitor of metalloproteinase 1 [TIMP-1]) using immunoassays, utilizing serum, to generate a prognostic algorithm reported as a risk score for liver fibrosis and liver-related clinical events within five years.
CPT Code 0015M
CPT 0015M describes a biochemical assay of 25 steroid markers utilizing a 24-hour urine specimen and clinical parameters, with a prognostic algorithm reported as a clinical risk and integrated clinical steroid risk for adrenal cortical carcinoma, adenoma, or other adrenal malignancy.
CPT Code 0016M
CPT 0016M describes mRNA microarray gene expression profiling of 219 genes utilizing formalin-fixed paraffin-embedded tissue, with an algorithm reported as a molecular subtype (luminal, luminal infiltrated, basal, basal claudin-low, neuroendocrine-like), for oncology (bladder).